DNQX-induced toxicity in cultured rat hippocampal neurons: An apparent AMPA receptor-independent effect?

Neurochemistry International

Volumn 42, Issue 3, 2003, Pages 251-260

  Martin, Alexandra ^a   Récasens, Max ^a   Guiramand, Janique ^a  

^a UNIV MONTPELLIER   (France)

Author keywords

AMPA receptors; DNQX; MTT assays; Neuronal cultures; Neurotoxicity; Rat

Indexed keywords

1 (4 AMINOPHENYL) 4 METHYL 7,8 METHYLENEDIOXY 5H 2,3 BENZODIAZEPINE; 2 AMINO 5 PHOSPHONOVALERIC ACID; 6 NITRO 7 SULFAMOYLBENZO[F]QUINOXALINE 2,3 DIONE; 6,7 DINITRO 2,3 QUINOXALINEDIONE; 7 CHLOROKYNURENIC ACID; ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID; AMPA RECEPTOR; AMPA RECEPTOR ANTAGONIST; CYCLOTHIAZIDE; DEXTRO SERINE; DIZOCILPINE; IONOTROPIC RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; CELL CULTURE; CELL SURVIVAL; CONTROLLED STUDY; DRUG EFFECT; GLIA CELL; HIPPOCAMPUS; NERVE CELL; NERVE CELL NECROSIS; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT; REGULATORY MECHANISM;

ANIMALS; CELLS, CULTURED; EXCITATORY AMINO ACID AGONISTS; EXCITATORY AMINO ACID ANTAGONISTS; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; NEURONS; QUINOXALINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, AMPA;

EID: 0037290233     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0197-0186(02)00089-X     Document Type: Article

References (44)

1. Aamodt S.M., Constantine-Paton M. The role of neural activity in synaptic development and its implications for adult brain function. Adv. Neurol. 79:1999;133-144.
2. Balazs R., Hack N., Resink A., Aronica E., Van der Valk J.B.F. Trophic effects of excitatory amino acids on differentiating granule cells involvement of calcium and second messengers. Mol. Pharmacol. 2:1992;203-206.
3. Balazs R., Jorgensen O.S., HacK N. N-methyl-D-aspartate promotes the survival of cerebellar granule cells in culture. Neuroscience. 27:1988;437-451.
4. Bal-Price A., Brown G.C. Inflammatory neurodegeneration mediated by nitric oxide from actived glia-inhibiting neuronal respiration, causing glutamate release and excitotoxicity. J. Neurosci. 21:2001;6480-6491.
5. Bardoul M., Drian M.J., König N. AMPA/kainate receptors modulate the survival in vitro of embryonic brainstem cells. Int. J. Dev. Neurosci. 15:1997;695-701.
6. Beattie E.C., Carroll R.C., Yu X., Morishita W., Yasuda H., von Zastrow M., Malenka R.C. Regulation of AMPA receptor endocytosis by a signaling mechanism shared with LTD. Nat. Neurosci. 3:2000;1291-1300.
7. Birch P.J., Grossman C.J., Hayes A.G. 6,7-Dinitro-quinoxaline-2,3-dion and 6-nitro,7-cyano-quinoxaline-2,3-dion antagonise responses to NMDA in the rat spinal cord via an action at the strychnine-insensitive glycine receptor. Euro. J. Pharmacol. 156:1988;177-180.
8. Blanc E.M., Jallageas M., Recasens M., Guiramand J. Potentiation of glutamatergic agonist-induced inositol phosphate formation by basic fibroblast growth factor is related to developmental features in hippocampal cultures: neuronal survival and glial cell proliferation. Euro. J. Neurosci. 10:1999;3377-3386.
9. Bleakman D., Ballyk B.A., Schoepp D.D., Palmer A.J., Bath C.P., Sharpe E.F., Woolley M.L., Bufton H.R., Kamboj R.K., Tarnawa I., Lodge D. Activity of 2,3-benzodiazepines at native rat and recombinant human glutamate receptors in vitro: stereospecificity and selectivity profiles. Neuropharmacology. 35:1996;1689-1702.
10. Bortolotto Z.A., Clarke V.R., Delany C.M., Parry M.C., Smolders I., Vignes M., Ho K.H., Miu P., Brinton B.T., Fantaske R., Ogden A., Gates M., Ornstein P.L., Lodge D., Bleakman D., Collingridge G.L. Kainate receptors are involved in synaptic plasticity. Nature. 402:1999;297-301.
11. Brickley S.G., Farrant M., Swanson G.T., Cull-Candy S.G. CNQX increases GABA-mediated synaptic transmission in the cerebellum by an AMPA/kainate receptor-independent mechanism. Neuropharmacology. 41:2001;730-736.
12. Burgoyne R.D., Graham M.E., Cambray-Deakin M. Neurotrophic effects of NMDA receptor activation on developing cerebellar granule cells. J. Neurocytol. 22:1993;689-695.
13. Castillo P.E., Malenka R.C., Nicoll R.A. Kainate receptors mediate a slow postsynaptic current in hippocampal CA3 neurons. Nature. 388:1997;182-186.
14. Choi D.W. Glutamate neurotoxicity in cortical cell culture is calcium dependent. Neurosci. Lett. 58:1985;293-297.
15. Choi D.W. Ionic dependence of glutamate neurotoxicity. J. Neurosci. 7:1987;369-379.
16. Drejer J., Honoré T. New quinoxalinediones show potent antagonism of quisqualate responses in cultured mouse cortical neurons. Neurosci. Lett. 87:1988;104-108.
17. 3H ] nitro-7-sulphamoylbenzo[f]-quinoxaline-2,3-dione to rat brain J. Neurochem. 67:1996;2609-2612.
18. Didier M., Heaulme M., Soubrie P., Bockaert J., Pin J.P. Rapid sensitive, and simple method for quantification of both neurotoxic and neurotrophic effects of NMDA on cultured cerebellar granule cells. J. Neurosci. Res. 27:1990;25-35.
19. Donevan S.D., Rogawski M.A. GYKI 52466, a 2,3-benzodiazepine, is a highly selective, noncompetitive antagonist of AMPA/kainate receptor responses. Neuron. 10:1993;51-59.
20. Drian M.J., Bardoul M., König N. Blockade of AMPA/kainate receptors can either decrease or increase the survival of cultured neocortical cells depending on the stage of maturation. Neurochem. Int. 38:2001;509-517.
21. Gallo V., Russell J.T. Excitatory amino acid receptors in glia: different subtypes for distinct fonctions? J. Neurosci. Res. 42:1995;1-8.
22. Honoré T., Davies S.N., Drejer J., Fletcher E.J., Jacobsen P., Lodge D., Nielsen F.E. Quinoxalinediones: potent competitive non-NMDA glutamate receptor antagonists. Science. 241:1988;701-703.
23. Ikonomidou C., Stefovska V., Turski L. Neuronal death enhanced by N-methyl-D-aspartate antagonists. Proc. Natl. Acad. Sci. U.S.A. 97:2000;12885-12890.
24. Kaczmarek L., Kossut M., Skangiel-Kramska J. Glutamate receptors in cortical plasticity: molecular and cellular biology. Physiolog. Rev. 77:1997;217-255.
25. Kessler M., Baudry M., Lynch G. Quinoxaline derivatives are high-affinity antagonists of the NMDA receptor-associated glycine sites. Brain Res. 489:1989;377-382.
26. Kleckner N.W., Dingledine R. Selectivity of quinoxalines and kynurenines as antagonists of the glycine site on N-methyl-D-aspartate receptors. Mol. Pharmacol. 36:1989;430-436.
27. Koh J.Y., Goldberg M.P., Hartley D.M., Choi D.W. Non-NMDA receptor-mediated neurotoxicity in cortical culture. J. Neurosci. 10:1990;693-705.
28. Leeson P.D., Baker R., Carling R.W., Curtis N.R., Moore K.W., Williams B.J., Foster A.C., Donald A.E., Kemp J.A., Marshall G.R. Kynurenic acid derivatives: structure-activity relationships for excitatory amino acid antagonism and identification of potent and selective antagonists at the glycine site on the N-methyl-D-aspartate receptor. J. Med. Chem. 34:1991;1243-1252.
29. Lester R.A., Ouarum M.L., Parker J.D., Weber E., Jahr C.E. Interaction of 6-cyano-7-nitroquinoxaline-2,3-dione with the N-methyl-D-aspartate receptor-associated glycine binding site. Mol. Pharmacol. 35:1989;565-570.
30. Lin J.W., Ju W., Foster K., Lee S.H., Ahmadian G., Wyszynski M., Wang Y.T., Sheng M. Distinct molecular mechanism and divergent endocytotic pathways of AMPA receptor internalization. Nat. Neurosci. 3:2000;1282-1290.
31. Lissin D.V., Carroll R.C., Nicoll R.A., Malenka R.C., von Zastrow M. Rapid, activation-induced redistribution of ionotropic glutamate receptors in cultured hippocampal neurons. J. Neurosci. 19:1999;1263-1272.
32. Maher P. How Protein Kinase C activation protects nerve cells from oxidative stress-induced cell death. J. Neurosci. 21:2001;2929-2938.
33. McBain C.J., Eaton J.V., Brown T., Dingledine R. CNQX increases spontaneous inhibitory input to CA3 pyramidal neurones in neonatal rat hippocampal slices. Brain Res. 592:1992;255-260.
34. McDonald J.W., Johnston M.V. Physiological and pathophysiological roles of excitatory amino acids during central nervous system development. Brain Res. Rev. 15:1990;41-70.
35. Murphy T.H., Miyamoto M., Sastre A., Schnaar R.L., Coyle J.T. Glutamate toxicity in neuronal cell line involves inhibition of cystine transport leading to oxidative stress. Neuron. 2:1989;1547-1558.
36. Ogita K., Suzuki T., Yoneda Y. Strychnine-insensitive binding of [3H]glycine to synaptic membranes in rat brain, treated with Triton X-100. Neuropharmacology. 28:1989;1263-1270.
37. Olney J.W. Brain lesions, obesity and other disturbances in mice treated with monosodium glutamate. Science. 164:1969;719-721.
38. Patneau D.K., Wright P.T., Winters C., Mayer M.L., Gallo V. Glial cells of the oligodendrocyte lineage express both kainate- and AMPA-preferring subtypes of glutamate receptor. Neuron. 12:1994;357-371.
39. Partin K.M., Patneau D.K., Winters C.A., Mayer M.L., Buonanno A. Selective modulation of desensitization at AMPA versus kainate receptors by cyclothiazide and concanavalin A. Neuron. 11:1993;1069-1082.
40. Partin K.M., Patneau D.K., Mayer M.L. Cyclothiazide diffenrentially modulates desensitization of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor splice variants. Mol. Pharmacol. 46:1994;129-138.
41. Rivera S., Guillot S., Agassandian C., Ben Ari Y., Khrestchatisky M. Serum deprivation-induced apoptosis in cultured hippocampi is prevented by kainate. Neuroreport. 9:1998;3949-3953.
42. Seifert G., Steinhauser C. Ionotropic glutamate receptors in astrocytes. Prog. Brain Res. 132:2001;287-299.
43. Wilding T.J., Huettner J.E. Differential antagonism of alpha-amino-3-hydroxy-5-methyl-4- isoxazolepropionic acid-preferring and kainate-preferring receptors by 2,3-benzodiazepines. Mol. Pharmacol. 47:1995;582-587.
44. Yuzaki M., Forrest D., Verselis L.M., Sun S.C., Curan T., Connor J.A. Functional NMDA receptors are transiently active and support the survival of Purkinje cells in culture. J. Neurosci. 16:1996;4651-4661.